CNDR in the News
The National Institute on Aging has extended its funding of the University of Pennsylvania's Alzheimer's Disease Core Center with a promise of about $8.8 million over five years.The money will take the center, which was founded in 1991, to its 30th year.
Eli Lilly has spent almost three decades working on drugs for Alzheimer’s disease with not much to show for it yet. This year the company began human tests using a totally new approach.
Researchers from the Perelman School of Medicine at the University of Pennsylvania are joining with scientists from five other institutions to establish the Coordinating Center for Genetics and Genomics of Alzheimer’s Disease.
Muhammad Ali was still boxing professionally when observers first noticed signs of neurological decline, and many have been quick to link his profession to his diagnosis, years later, of Parkinson’s disease.
In the early stages of Alzheimer’s disease, an overzealous set of proteins and cells begins to chew away at the brain’s nerve cell connections, a study in mice suggests.
Mark Karasow and his wife, Connie Bastek-Karasow, are part of a giant national experiment to determine whether more precise diagnoses can help patients with hard-to-diagnose dementia symptoms even though there still is little medical help for them.
Diseases and disorders can vary greatly between the sexes. Here, Philly’s finest doctors and medical centers share how women can sleep better, look younger, and live longer.
Specialists at the Perelman School of Medicine are conducting research to better understand, prevent, and treat concussions and affiliated diseases, such as chronic traumatic encephalopathy.
Specialists have long suspected that symptoms progressed more slowly in Parkinson's disease patients whose main problem was tremors, rather than walking or balance.
Related News Releases
August 2, 2016
July 18, 2016
Penn Medicine Announces $3 Million Gift to Establish Unique Pulmonary Program for Patients with Amyotrophic Lateral Sclerosis (ALS) and other Neurodegenerative Diseases
July 12, 2016
Penn Medicine Team and Collaborators Receive NIH Award to Launch Genomics Center on Alzheimer's disease
June 22, 2016
June 20, 2016
April 21, 2016
Penn Study Uncovers Genetic Variation that Predicted Type and Rate of Physical Decline in Patients with Parkinson's Disease
April 14, 2016
March 23, 2016
March 22, 2016
Penn Medicine Wins NIH Award to Study Progressive Brain Damage from Concussions and More Severe Traumatic Brain Injuries
March 17, 2016
Penn-Engineered Neural Networks Show Hope for Axonal Repair in the Brain, with Minimal Disruption to Brain Tissue
January 19, 2016
Penn's Murray Grossman Receives Special Recognition Award from the Legal Clinic for the Disabled for Dedication to the Disability Community
December 31, 2015
Brain's Hippocampus is Essential Structure for All Aspects of Recognition Memory, Penn Medicine Researchers Find
November 3, 2015
July 21, 2015
Higher-level Occupations May Increase Survival in Patients with a Common Form of Early-onset Demtia, Finds New Penn Medicine Research
April 22, 2015
Two Penn Medicine Studies Examine Diabetes Severity in Parkinson's and Sex Differences in Parkinson's Caregiving
April 21, 2015
Plasma Ap0A1 Associates with Age at Onset and Motor Severity in Early Parkinson's Disease Patients, Penn Medicine Researchers Find
April 17, 2015
Penn Medicine Researchers Pinpoint Potential New Drug Target for Protection Against Certain Neurodegenerative Diseases
March 20, 2015
January 22, 2015
December 17, 2014
November 13, 2014
Penn Study Finds Dopamine Replacement Therapy Associated with Increase in Impulse Control Disorders Among Early Parkinson's Disease Patients
August 15, 2014
Penn Physiologist Given NIH Javits Neuroscience Investigator Award for Research on Neurodegeneration
August 4, 2014
August 1, 2014
Penn Researchers Find Naltrexone May Be Effective in Diminishing Impulse Control Disorders in Parkinson's Disease Patients
July 30, 2014
July 17, 2014
Penn Medicine Researchers and Collaborators Receive $12.6 Million NIH Grant to Study Genetics of Alzheimer's Disease
July 7, 2014
June 12, 2014
May 29, 2014
May 14, 2014
Role of Calcium in Familial Alzheimer's Disease Clarified in Penn Study, Pointing to New Therapeutic Options
May 13, 2014
Penn Neurologists Report on Promise of Statins, Estrogen and Telemedicine as Potential Targets and Interventions for Parkinson's Disease
April 25, 2014
April 8, 2014
Penn Medical Ethicist: Policy Changes Urgently Needed as Millions of Americans to Start Receiving Early Label of Alzheimer's Disease
April 7, 2014
Alzheimer's Prevention Trial To Evaluate and Monitor Participants' Reactions to Learning of Higher Disease Risk Status
March 19, 2014
A Common Protein in an Uncommon Role: Unraveling Misfolded Molecules Using "Reprogrammed" Yeast Protein Could Lead to New Brain Disease Therapies
January 16, 2014
November 25, 2013
November 18, 2013
International Group Finds 11 New Alzheimer's Genes to Target for Drug Discovery, Adding New Clues into Complex Disease Puzzle
October 28, 2013
Comprehensive Parkinson's Biomarker Test Has Prognostic and Diagnostic Value, Penn Medicine Team Reports
August 26, 2013
July 10, 2013
Shape-shifting Disease Proteins May Explain Variable Appearance of Neurodegenerative Diseases, Penn Study Finds
July 3, 2013
June 19, 2013
© The Trustees of the University of Pennsylvania | Site best viewed in a supported browser. | Site Design: PMACS Web Team.